| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +30,000 | 26% | $7.57 | +$227,010 |
| Sells | 7 | -83,780 | 74% | $13.75 | -$1,152,245 |
| Net | -6 | -53,780 | -47% | -$925,235 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| John G. Houston | President and CEO, Director | $22,868,294 | -$523,881 | -2.2% | 24 Feb 2025 |
| Sean A. Cassidy | Chief Financial Officer | $8,559,148 | 23 Feb 2024 | ||
| Ronald Peck | Chief Medical Officer | $4,106,228 | 23 Feb 2024 | ||
| Noah Berkowitz | Chief Medical Officer | $3,298,502 | -$141,967 | -4.1% | 13 Feb 2026 |
| Ian Taylor | President, R&D | $3,137,181 | -$150,752 | -4.6% | 24 Feb 2025 |
| Andrew Saik | Chief Financial Officer | $3,093,044 | -$104,420 | -3.3% | 13 Feb 2026 |
| Angela M. Cacace | Chief Scientific Officer | $2,997,508 | -$144,184 | -4.6% | 13 Feb 2026 |
| Randy Teel | President and CEO, Director | $1,836,790 | -$52,352 | -2.8% | 13 Feb 2026 |
| Briggs Morrison | Director | $720,370 | +$227,010 | +46% | 22 Sep 2025 |
| David K. Loomis | Chief Accounting Officer | $625,028 | -$34,689 | -5.3% | 13 Feb 2026 |
| Edward Moore Kennedy Jr. | Director | $590,016 | 25 Jun 2025 | ||
| WENDY L. DIXON | Director | $350,528 | 15 Jun 2023 | ||
| SUNIL AGARWAL | Director | $340,294 | 25 Jun 2025 | ||
| Alsup Laurie Smaldone | Director | $313,631 | 25 Jun 2025 | ||
| Linda Bain | Director | $313,631 | 25 Jun 2025 | ||
| Everett Cunningham | Director | $313,631 | 25 Jun 2025 | ||
| Leslie Norwalk V. | Director | $313,631 | 25 Jun 2025 | ||
| JOHN D. YOUNG | Director | $313,631 | 25 Jun 2025 | ||
| Bradley Albert Margus | Director | $163,072 | 16 Jun 2022 | ||
| Liam Ratcliffe | Director | $163,072 | 16 Jun 2022 | ||
| TIMOTHY M. SHANNON | Director | $163,072 | 16 Jun 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|